and followed the principles of the Declaration of Helsinki. The cell lines HeLa, TPC1, CAPAN-2, 293, HEPG2, A549, Caco-2 and MCF7 were culturedin Dulbecco's modified Eagle's medium and RT4 was cultured in McCoy's 5A medium. Cells were supplemented with 10% fetal bovine serum at 37˚C and 5% CO 2 . The coding sequence of type 2 taste receptor 10 (TAS2R10) was subcloned into pcDNA3.1 to construct the TAS2R10 expression plasmid. Transfection was performed with Lipofectamine™ 2000 (Invitrogen; Thermo Fisher Scientifc, Inc.) according to the manufacturer's protocol.
Reverse transcription-quantitative (RT-q)PCR. Total RNA of tissues and cell lines was extracted with TRIzol reagent (Invitrogen; Thermo Fisher Scientifc, Inc.). RT-qPCR analysis of mRNA expression was performed on a LightCycler 480 (Roche) with SYBR Green PCR master mix (Applied Biosystems; Thermo Fisher Scientific, Inc.). All reactions were run in quadruplicate. β-actin was used as the endogenous control. The 2 -ΔΔCq method was used to calculate fold changes for data analysis.
Western blot analysis. Cell lysates were separated by SDS-PAGE and transferred to polyvinylidene difluoride membranes (Bio-Rad Laboratories, Inc.). Membranes were blocked in Tris-buffered saline containing 0.05% Tween-20 and 5% skimmed milk, and subsequently incubated with primary antibodies against TAS2R10 (Novus Biologicals, Ltd.) and β-actin (Santa Cruz Biotechnology, Inc.) overnight at 4˚C, followed by incubation with horseradish peroxidase-labeled secondary antibodies for 2 h. Protein expression was assessed via enhanced chemiluminescence (BOSER). Figure S1 . Expression of TAS2R10 in different cell lines detected by (A) reverse transcription-quantitative PCR and (B) western blot analysis. Lanes: 1, Hela; 2, TPC1; 3, CAPAN-2; 4, 293; 5, HEPG2; 6, RT4; 7, A549; 8, Caco-2; 9, MCF7. TAS2R10 was mainly expressed in the cell lines of Hela, TPC1 and CAPAN-2. Values are expressed as the mean ± standard deviation of four independent experiments. * P<0.05. TAS2R10, type 2 taste receptor 10. Figure S2 . Expression of TAS2R10 and ANAPC5 in thyroid tissue detected by reverse transcription-quantitative PCR. (A) Analysis of 4 pairs of clinical samples of human thyroid cancer. When the expression of TAS2R10 was decreased in thyroid cancer, ANAPC5 was also decreased. (B) The thyroid cancer cell line TPC-1 was employed and overexpression experiments were performed. When TAS2R10 was overexpressed, ANAPC5 was also increased. Values are expressed as the mean ± standard deviation of four independent experiments. * P<0.05. Co, control; Ov, overexpression; No, normal; Ca, Cancer; TAS2R10, type 2 taste receptor 10; ANAPC5, anaphase promoting complex subunit 5.
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